TRANSMEDICS GROUP INC (TMDX) Stock Analyst Ratings
NASDAQ:TMDX - Nasdaq - US89377M1099 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 81% to TMDX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 113.11. This target is 57.2% above the current price.
TMDX was analyzed by 17 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about TMDX.
In the previous month the buy percentage consensus was at a similar level.
TMDX was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-05 | Needham | Reiterate | Hold -> Hold |
| 2024-12-17 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-12-11 | Needham | Reiterate | Hold -> Hold |
| 2024-12-11 | Baird | Maintains | Outperform -> Outperform |
| 2024-12-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-03 | Needham | Reiterate | Hold -> Hold |
| 2024-12-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-22 | Needham | Downgrade | Buy -> Hold |
| 2024-11-20 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-20 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-18 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-29 | Needham | Maintains | Buy -> Buy |
| 2024-10-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-29 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-29 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-10-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-09-24 | Baird | Initiate | Outperform |
| 2024-08-23 | Needham | Reiterate | Buy -> Buy |
| 2024-08-21 | Needham | Initiate | Buy |
| 2024-08-02 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2024-08-01 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-07-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-07 | TD Cowen | Maintains | Buy -> Buy |
| 2024-06-04 | Stephens & Co. | Initiate | Overweight |